AGM Statement

Orchard Funding Group PLC
09 January 2024
 

9th January 2024

 

Orchard Funding Group PLC

("Orchard" or the "Company")

 

Dividend Timetable

 

Orchard Funding Group PLC, the finance company which specialises in insurance premium finance and the professions funding market, confirms that subject to approval at Orchard's upcoming annual general meeting (the "AGM"), to be held at 10am on Thursday 11 January 2024, the Company's final dividend for the year of 2.0 pence per share will follow the below timetable:

 

Ex-Dividend Date: 18 January 2024

Record Date: 19 January 2024

 

The final dividend will be paid to shareholders as soon as possible following the record date. These ex-dividend and record date replace the proposed dates set out in the Company's AGM notice. Following payment of the final dividend, the Company's full year dividend for FY23 will be 3.0 pence per share.

 

Shareholders have the option of attending the AGM on Teams with the details set out below:

 

www.microsoft.com/en-gb/microsoft-teams/join-a-meeting

 

Meeting ID - 347 560 623 601

 

Passcode - GG6E9X

 

For further information, please contact:

 

Orchard Funding Group PLC                                       +44 (0)1582 346 248

Ravi Takhar, Chief Executive Officer

 

Liberum (Nomad and Broker)                                       +44 (0)20 3100 3222

Investment banking

Lauren Kettle

Chris Clarke

 

For Investor Relations please go to: www.orchardfundinggroupplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings